US Patent Issued to GENMAB HOLDING on March 17 for "Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies" (Dutch, American Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,316, issued on March 17, was assigned to GENMAB HOLDING B.V. (Utrecht, Netherlands).

"Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies" was invented by Simone Oostindie (Utrecht, Netherlands), Frank Beurskens (Utrecht, Netherlands), Esther Breij (Utrecht, Netherlands), Edward Van Den Brink (Utrecht, Netherlands), Andreas Hollenstein (Utrecht, Netherlands), Marije Overdijk (Utrecht, Netherlands), Margaret Lindorfer (Keswick, Va.), Ronald Taylor (Keswick, Va.), Paul Parren (Odijk, Netherlands), Hilma Van Der Horst (Utrecht, Netherlands), Martine E.D. Chamuleau (Amsterdam) and Tuna Mutis (Amsterdam).

According to the abstract* released by the U.S. Patent & Tr...